![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 48, 46073-46078, November 29, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Infection, Inflammation and Repair Division, School of
Medicine, University of Southampton, 97 Tremona Rd., Southampton
General Hospital, Southampton SO16 6YD, United Kingdom
Interleukin (IL)-13 is a key cytokine associated
with the asthmatic phenotype. It signals via its cognate receptor, a
complex of IL-13 receptor
Kinetic Analysis of the Interleukin-13 Receptor Complex*
,
1 chain (IL-13R
1) with IL-4R
;
however, a second protein, IL-13R
2, also binds IL-13. To determine
the binding contributions of the individual components of the IL-13
receptor to IL-13, we have employed surface plasmon resonance and
equilibrium binding assays to investigate the ligand binding
characteristics of shIL-13R
1, shIL-13R
2, and IL-4R
.
shIL-13R
1 bound IL-13 with moderate affinity (KD = 37.8 ± 1.8 nM, n = 10), whereas no
binding was observed for hIL-4R
. In contrast, shIL-13R
2 produced
a high affinity interaction with IL-13 (KD = 2.49 ± 0.94 nM n = 10). IL-13R
2
exhibited the binding characteristics of a negative regulator with a
fast association rate and an exceptional slow dissociation rate.
Although IL-13 interacted weakly with IL-4R
on its own
(KD > 50 µM), the presence of
hIL-4R
significantly increased the affinity of shIL-13R
1 for
IL-13 but had no effect on the binding affinity of IL-13R
2. Detailed
kinetic analyses of the binding properties of the heteromeric complexes suggested a sequential mechanism for the binding of IL-13 to its signaling receptor, in which IL-13 first binds to IL-13R
1 and this
then recruits IL-4R
to stabilize a high affinity interaction.
*
This work was supported in part by the Medical Research
Council (MRC), United Kingdom (Grant G4500010).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
An MRC Training Fellow.
§
To whom correspondence should be addressed. Tel.: 23-80-798-523;
Fax: 23-80-777-996; E-mail: donnad@soton.ac.uk.
This article has been cited by other articles:
![]() |
M. T. Kasaian, X.-Y. Tan, M. Jin, L. Fitz, K. Marquette, N. Wood, T. A. Cook, J. Lee, A. Widom, R. Agostinelli, et al. Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 882 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Andrews, J. W. Holloway, S. T. Holgate, and D. E. Davies IL-4 Receptor {alpha} Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets. J. Immunol., June 15, 2006; 176(12): 7456 - 7461. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arima, K. Sato, G. Tanaka, S. Kanaji, T. Terada, E. Honjo, R. Kuroki, Y. Matsuo, and K. Izuhara Characterization of the Interaction between Interleukin-13 and Interleukin-13 Receptors J. Biol. Chem., July 1, 2005; 280(26): 24915 - 24922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |